loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for DSSTox_CID_3557

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    DSSTox_CID_3557

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eiger Begins Enrollment in LIMT-2 Phase 3 Study of Peginterferon Lambda
    Eiger Begins Enrollment in LIMT-2 Phase 3 Study of Peginterferon Lambda

    21 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-first-patient-enrolled-in-limt-2-a-phase-3-study-of-peginterferon-lambda-in-patients-with-chronic-hepatitis-delta-virus-hdv-infection-301449320.html

    PRNEWSWIRE
    21 Dec 2021
    Share Share
    Triple drug combination shows promise in Covid-19 treatment
    Triple drug combination shows promise in Covid-19 treatment

    11 May 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/triple-drug-combo-covid-19/

    CLINICALTRIALSARENA
    11 May 2020
    Share Share
    Bausch Health initiates VIRAZOLE trial in Covid-19 patients
    Bausch Health initiates VIRAZOLE trial in Covid-19 patients

    15 Apr 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/bausch-health-initiates-virazole-trial/

    CLINICALTRIALSARENA
    15 Apr 2020
    Share Share
    Bausch Health begins clinical study in Canada evaluating Virazole in combo
    Bausch Health begins clinical study in Canada evaluating Virazole in combo

    13 Apr 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=122429&sid=2

    PHARMABIZ
    13 Apr 2020
    Share Share
    Can old drugs take down a new coronavirus?
    Can old drugs take down a new coronavirus?

    13 Mar 2020

    // Lisa M. Jarvis C&EN

    https://cen.acs.org/sections/coronavirus/biological-chemistry/infectious-disease/coronavirus-drug-repurposing.html

    Lisa M. Jarvis C&EN
    13 Mar 2020
    Share Share
    Biogen Idec's Plegridy (Peginterferon beta-1a) Receives Supplemental Approval In US
    Biogen Idec's Plegridy (Peginterferon beta-1a) Receives Supplemental Approval In US

    12 Jul 2019

    //

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499

    12 Jul 2019
    Share Share